Viewing StudyNCT00400569

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00400569
Status: COMPLETED
Last Update Posted: 2012-08-28
First Post: 2006-11-15
Brief Title: Phase II Study of Sunitinib Malate for Metastatic andor Surgically Unresectable Soft Tissue Sarcoma
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Liposarcoma
Leiomyosarcoma
Fibrosarcoma
Malignant Fibrous Histiocytoma
Keywords:
Name View
Sunitinib malate View
SUTENT View
SU011248 View
Soft tissue sarcoma View
Gastrointestinal stromal tumors GIST View
MFH View
Tyrosine kinase inhibitor View
Imatinib mesylate View
Phase II View